Paul Daruwala
2018
In 2018, Paul Daruwala earned a total compensation of $662.4K as Chief Operating Officer at Cidara Therapeutics, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,800 |
|---|---|
| Option Awards | $202,622 |
| Salary | $355,000 |
| Total | $662,422 |
Daruwala received $355K in salary, accounting for 54% of the total pay in 2018.
Daruwala also received $104.8K in non-equity incentive plan and $202.6K in option awards.
Rankings
In 2018, Paul Daruwala's compensation ranked 10,927th out of 14,244 executives tracked by ExecPay. In other words, Daruwala earned more than 23.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,927 out of 14,244 | 23rd |
Division Manufacturing | 4,408 out of 5,765 | 24th |
Major group Chemicals And Allied Products | 1,665 out of 2,128 | 22nd |
Industry group Drugs | 1,412 out of 1,817 | 22nd |
Industry Biological Products, Except Diagnostic Substances | 273 out of 339 | 20th |
Source: SEC filing on April 26, 2019.
Daruwala's colleagues
We found three more compensation records of executives who worked with Paul Daruwala at Cidara Therapeutics in 2018.